Literature DB >> 11796735

Identification and characterization of two cation binding sites in the integrin beta 3 subunit.

Aleksandra Cierniewska-Cieslak1, Czeslaw S Cierniewski, Kamila Bledzka, Kamila Blecka, Malgorzata Papierak, Lidia Michalec, Li Zhang, Thomas A Haas, Edward F Plow.   

Abstract

The midsegment of the beta(3) subunit has been implicated in the ligand and cation binding functions of the beta(3) integrins. This region may contain a metal ion-dependent adhesion site (MIDAS) and fold into an I domain-like structure. Two recombinant fragments, beta(3)-(95-373) and beta(3)-(95-301), were expressed and found to bind fibrinogen. Whereas 0.1 mm Ca(2+) supported ligand binding to both recombinant fragments, 1.0 mm Ca(2+) suppressed binding to the longer but not the shorter fragment. These properties suggest that beta(3)-(95-373) contains both the ligand-competent (LC) and inhibitory (I) cation binding sites, and beta(3)-(95-301) lacks the I site. In equilibrium dialysis experiments, beta(3)-(95-373) contained two divalent cation binding sites, one reactive with either Mg(2+) or Ca(2+) and one Ca(2+)-specific, whereas beta(3)-(95-301) lacked the Ca(2+)-specific site. Mutant forms of beta(3)-(95-373) suggested that the LC site is a MIDAS motif involving Asp(119), Ser(121), Ser(123), Asp(217), and/or Glu(220) as coordination sites, and the I site was dependent upon residues within beta(3)-(301-323). In a molecular model of beta(3)-(95-373), a second Ca(2+) could be docked onto a flexible loop in close proximity to the MIDAS. These results indicate that the ligand competent and Ca(2+)-specific inhibitory cation binding sites are distinct and reside in beta(3)-(95-373).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796735     DOI: 10.1074/jbc.M112388200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  The regulation of integrin function by divalent cations.

Authors:  Kun Zhang; JianFeng Chen
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

2.  Three-Dimensional Modeling of Thyroid Hormone Metabolites Binding to the Cancer-Relevant αvβ3 Integrin: In-Silico Based Study.

Authors:  Dror Tobi; Eilon Krashin; Paul J Davis; Vivian Cody; Martin Ellis; Osnat Ashur-Fabian
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-27       Impact factor: 6.055

3.  Functional and computational studies of the ligand-associated metal binding site of beta3 integrins.

Authors:  Marta Murcia; Marketa Jirouskova; Jihong Li; Barry S Coller; Marta Filizola
Journal:  Proteins       Date:  2008-06

4.  The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3.

Authors:  Steven B Ludbrook; Simon T Barry; Chris J Delves; Carmel M T Horgan
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

5.  Pathogenic activity of circulating anti-desmoglein-3 autoantibodies isolated from pemphigus vulgaris patients.

Authors:  Joanna Narbutt; Joanna Boncela; Katarzyna Smolarczyk; Cezary Kowalewski; Katarzyna Wozniak; Jolanta Dorota Torzecka; Anna Sysa-Jedrzejowska; Czesław S Cierniewski; Aleksandra Lesiak
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

6.  Variation in one residue associated with the metal ion-dependent adhesion site regulates αIIbβ3 integrin ligand binding affinity.

Authors:  Joel Raborn; Ting Fu; Xue Wu; Zhilong Xiu; Guohui Li; Bing-Hao Luo
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

7.  Slow Freezing Versus Vitrification of Mouse Ovaries: from Ex Vivo Analyses to Successful Pregnancies after Auto-Transplantation.

Authors:  Carmen Terren; Maïté Fransolet; Marie Ancion; Michelle Nisolle; Carine Munaut
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

Review 8.  Insights into integrin-ligand binding and activation from the first crystal structure.

Authors:  Martin J Humphries
Journal:  Arthritis Res       Date:  2002-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.